Table 4 Correlation between AURKA intensity and clinical features based on the published raw data
Parameter | Characteristic | No. patients (%) | AURKA intensity | Statistics | P value |
|---|---|---|---|---|---|
Location | Stomach | 40 (66.7) | 8.91 ± 1.25 |  F = 1.923 | 0.156 |
Non-stomach | 16 (26.7) | 9.64 ± 1.55 |  |  | |
Parenteral | 4 (6.7) | 9.47 ± 1.69 |  |  | |
AFIP risk* | High | 17 (28.3) | 10.2 ± 1.59 |  F = 8.686 | < 0.001 |
Intermediate | 14 (23.3) | 9.38 ± 1.43 |  |  | |
Low | 16 (26.7) | 8.48 ± 0.64 |  |  | |
Very low | 13 (21.7) | 8.34 ± 0.55 |  |  | |
Local recurrence* | No | 54 (90.0) | 8.83 ± 1.03 | t = 7.377 | < 0.001 |
Yes | 6 (10.0) | 12.0 ± 0.63 |  |  | |
Metastasis* | No | 45 (75.0) | 8.56 ± 0.82 | t = 6.921 | < 0.001 |
Yes | 15 (25.0) | 10.9 ± 1.22 |  |  | |
Mutation* | Sensitive | 45 (75.0) | 8.91 ± 0.18 | t = 2.442 | 0.018 |
Resistance | 15 (25.0) | 9.88 ± 0.44 |  |  |